TVGN

Tevogen Bio Holdings Inc.

There isn't enough reported data to score TVGN yet.

TVGN Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Strong

TVGN's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.

TVGN PE Valuation

TVGN has no meaningful PE right now: it lost money over the past year.

TVGN Forward outlook

MetricOutlook
--
Losses growing
--
--
Limited
High

Analysts expect TVGN's losses to grow, with revenue holding steady.

TVGN Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $5.72 on Nov 12.

There is not enough scenario data to assess TVGN's risk to reward.

TVGN Earnings Per Share

Q3 2024: $-17.00Q4 2024: $-3.50Q1 2025: $6.00Q2 2025: $6.50Q3 2025: $6.50Q4 2025: $-8.08Q1 2026: $-6.19Q2 2026: $-6.21
Q3 2024: $-17.00Q4 2024: $-3.50Q1 2025: $6.00Q2 2025: $6.50Q3 2025: $6.50Q4 2025: $-8.08Q1 2026: $-6.19Q2 2026: $-6.21
QuarterTTM EPSYoY
Q2 2026-$6.21-196%
Q1 2026-$6.19-203%
Q4 2025-$8.08-$4.58
Q3 2025$6.50+$23.50

TVGN has swung to a loss: it lost $6.21 per share over the past year, after a profit the year before.

TVGN Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

TVGN Free Cash Flow

Q3 2023: --Q4 2023: −$693,711Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: −$3MQ2 2025: −$3MQ3 2025: −$4MQ4 2025: −$2MQ1 2026: −$3MQ2 2026: −$3M
Q3 2023: --Q4 2023: −$693,711Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: −$3MQ2 2025: −$3MQ3 2025: −$4MQ4 2025: −$2MQ1 2026: −$3MQ2 2026: −$3M
QuarterFree cash flowYoY
Q2 2026-$3M+$184.3K
Q1 2026-$2.7M+$574.3K
Q4 2023-$693.7K-$679.9K
Q4 2022-$13.9K+$700K

TVGN has burned cash in almost every quarter: −$12M over the past year, against −$7M the year before.

TVGN Total Shares

Q4 2023: 3MQ1 2024: 3MQ2 2024: 3MQ3 2024: 3MQ1 2025: 3MQ2 2025: 4MQ3 2025: 4MQ1 2026: 3MQ2 2026: 4M
Q4 2023: 3MQ1 2024: 3MQ2 2024: 3MQ3 2024: 3MQ1 2025: 3MQ2 2025: 4MQ3 2025: 4MQ1 2026: 3MQ2 2026: 4M
PeriodChange %Net change
Quarterly+9.8%+343K shares
1 year+19%+601K shares

TVGN has 4M diluted shares, up 19% from a year ago.

TVGN Net Leverage

QuarterNet LeverageStatus
Q3 2022-0.1xNet Cash

TVGN has more cash than debt.

TVGN Weekly Momentum

MetricValueStatus
RSI37.7Neutral
Stochastic28.8Neutral

TVGN's weekly RSI is 38 (neutral) and its Stochastic is 29 (neutral).

TVGN PE vs Healthcare Sector

MetricTVGNSector medianRelative
PEN/A26x—

TVGN has no meaningful PE right now: it lost money over the past year.

TVGN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$6.4812% below
20 week MA$6.3910% below
50 week MA$9.4539% below
100 week MA$30.781% below
200 week MA$183.897% below

TVGN is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.

TVGN Yearly ROI

YearStart priceEnd priceROI
2022$496.5$515.0+3.7%
2023$515.0$556.5+8.1%
2024$556.5$51.5-91%
2025$51.5$19.0-63%
2026 YTD$19.0$5.72-70%

TVGN has finished lower in two of the last four years. It's down 70% so far in 2026.

Give your agent the market.

Get API key